RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,879 | -71.3% | 39,307 | -30.2% | 0.00% | – |
| Q3 2022 | $24,000 | -55.6% | 56,297 | -11.8% | 0.00% | – |
| Q2 2022 | $54,000 | -80.4% | 63,841 | +27.3% | 0.00% | – |
| Q1 2022 | $276,000 | -0.7% | 50,152 | +74.6% | 0.00% | – |
| Q4 2021 | $278,000 | -45.0% | 28,730 | +1.8% | 0.00% | – |
| Q3 2021 | $505,000 | -42.3% | 28,217 | -21.3% | 0.00% | -100.0% |
| Q2 2021 | $875,000 | -25.3% | 35,845 | -18.9% | 0.00% | 0.0% |
| Q1 2021 | $1,171,000 | +230.8% | 44,175 | -5.2% | 0.00% | – |
| Q4 2020 | $354,000 | +74.4% | 46,600 | +14.8% | 0.00% | – |
| Q3 2020 | $203,000 | -3.3% | 40,600 | +15.7% | 0.00% | – |
| Q2 2020 | $210,000 | +47.9% | 35,105 | +10.1% | 0.00% | – |
| Q1 2020 | $142,000 | -31.7% | 31,879 | +45.4% | 0.00% | – |
| Q4 2019 | $208,000 | +50.7% | 21,926 | +24.8% | 0.00% | – |
| Q3 2019 | $138,000 | -17.4% | 17,565 | +65.8% | 0.00% | – |
| Q2 2019 | $167,000 | -30.7% | 10,595 | -20.4% | 0.00% | -100.0% |
| Q1 2019 | $241,000 | +48.8% | 13,315 | +31.9% | 0.00% | – |
| Q4 2018 | $162,000 | – | 10,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |